Joseph M Letourneau

No ORCID on file · 2 papers in corpus
observational 2022
F&S reports ·doi:10.1016/j.xfre.2022.05.008

OBJECTIVE: To investigate the impact of chemotherapy on the uterus. DESIGN: Cross-sectional pilot study. SETTING: Single university fertility clinic. PATIENTS: Twelve patients with a history of alkylating agent chemotherapy exposure afte…

rct 2022
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02626-6

BACKGROUND: In this secondary analysis of the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) trial, we aimed to investigate if concurrent administration of letrozole vs. tamoxifen vs. no added treatment affects hormonal composi…